Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$81.24 - $97.37 $412,861 - $494,834
5,082 New
5,082 $420,000
Q1 2023

Dec 19, 2024

BUY
$72.75 - $90.6 $190,168 - $236,828
2,614 New
2,614 $216,000
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $190,168 - $236,828
2,614 New
2,614 $216,000
Q2 2020

Aug 10, 2020

SELL
$84.96 - $118.91 $10,110 - $14,150
-119 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$74.34 - $121.82 $8,846 - $14,496
119 New
119 $12,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.